Document is current
Any future updates will be listed below
-
Authors
Hervé, Julie
Haurogné, Karine
Buchet, Arnaud
Bacou, Elodie
Mignot, Grégoire
Allard, Marie
Leblanc-Maridor, Mily
Gavaud, Solenn
Lehébel, Anne
Terenina, Elena
Mormède, Pierre
Merlot, Elodie
Belloc, Catherine
Bach, Jean-Marie
Lieubeau, Blandine
-
Funding
Funding for this research was provided by:
INRAE-Metaprogramme GISA (Sevrobust, Sevrobust, Sevrobust, Sevrobust, Sevrobust, Sevrobust, Sevrobust)
Cooperl Innovation (PhD funding)
INRAE-Région Pays de la Loire (PhD funding)
- License Information
-
More Information
Article History
Received: 9 February 2022
Accepted: 30 November 2022
First Online: 10 December 2022
Declarations
:
: All experimental procedures were carried out in accordance with the European directive 2010/63/EU for animal experiments. They were submitted to and approved by the Oniris’ ethics committee for veterinary clinical research (decision CERVO-2016-6-V).
: Not applicable.
: PhD funding of AB was obtained from Cooperl Innovation, but Cooperl Innovation did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors declare no competing interest.
